Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture, Commercialize Blex 404

Author: Benzinga Newsdesk | May 09, 2024 08:41am

https://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390024041053/ea0205569-8k_abvcbio.htm

Posted In: ABVC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist